Chemotherapy Clinical Trials in Zhengzhou, Henan
4 recruitingZhengzhou, Henan, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN
Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Henan Cancer Hospital1,076 enrolled1 locationNCT07187908
Recruiting
Phase 1
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
ChemotherapyNon-small Cell Lung CancerPD1 Antibody+1 more
The First Affiliated Hospital of Zhengzhou University80 enrolled1 locationNCT06896422
Recruiting
Phase 2
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Locally Advanced Cervical CancerFemale, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy+6 more
The First Affiliated Hospital of Zhengzhou University29 enrolled1 locationNCT07104149
Recruiting
Phase 2
Toripalimab Plus FLOT in Locally Advanced Gastric Cancer
ChemotherapyLocally Advanced Gastric CarcinomaImmune Checkpoint Inhibitor
Henan Cancer Hospital60 enrolled1 locationNCT04891016